Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Visbiome for Inflammation and Microbial Translocation in HIV
NCT02441244Phase 2Terminated
- Sponsor
- University Health Network
- Start
- Nov 2015
- Primary completion
- Dec 2016
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of Visbiome in human immunodeficiency virus type 1 infection (HIV-1), sponsored by University Health Network. Started Nov 2015; status: terminated.
02
Drugs
Visbiome
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT02441244.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02441244.